| Nome |
# |
|
Abemaciclib: safety and effectiveness of a unique cyclin-dependent kinase inhibitor, file e3ad8922-d804-da0e-e053-3705fe0a2b96
|
454
|
|
Metastatic seeding of colon adenocarcinoma manifesting as synchronous breast and chest wall localization: report of a case., file e3ad8916-f0ec-da0e-e053-3705fe0a2b96
|
263
|
|
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9), file e3ad8927-6b0d-da0e-e053-3705fe0a2b96
|
212
|
|
Management of toxicities associated with targeted therapies for HR-positive metastatic breast cancer: a multidisciplinary approach is the key to success, file e3ad891f-5563-da0e-e053-3705fe0a2b96
|
208
|
|
Gastric and Rectal Metastases from Malignant Melanoma Presenting with Hypochromic Anemia and Treated with Immunotherapy, file e3ad891f-179e-da0e-e053-3705fe0a2b96
|
202
|
|
Metronomic Chemotherapy (mCHT) in HER2-ve Advanced Breast Cancer (ABC) Patients (PTS): When Care Objectives Meet Patients’ Need. Preliminary Results of the Victor-6 Study, file e3ad891f-60e2-da0e-e053-3705fe0a2b96
|
199
|
|
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical
outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo
Oncologico dell'Italia Meridionale (GOIM) prospective study., file e3ad891a-5380-da0e-e053-3705fe0a2b96
|
196
|
|
Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study, file e3ad8915-e9ab-da0e-e053-3705fe0a2b96
|
192
|
|
Clinical presentation and treatment of gastrointestinal stromal tumors., file e3ad891a-382f-da0e-e053-3705fe0a2b96
|
192
|
|
Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients, file e3ad8917-414a-da0e-e053-3705fe0a2b96
|
160
|
|
Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study, file e3ad8915-e4f9-da0e-e053-3705fe0a2b96
|
157
|
|
Hematologic toxicity of radium-223 in elderly patients with metastatic Castration Resistant Prostate Cancer: a real-life experience, file e3ad891f-3544-da0e-e053-3705fe0a2b96
|
129
|
|
Axillary Nodal Burden in Breast Cancer Patients With Pre-operative Fine Needle Aspiration-proven Positive Lymph Nodes Compared to Those With Positive Sentinel Nodes, file e3ad8921-9af0-da0e-e053-3705fe0a2b96
|
129
|
|
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study, file e3ad891f-1d21-da0e-e053-3705fe0a2b96
|
108
|
|
Virtual Multidisciplinary Tumor Boards: A Narrative Review Focused on Lung Cancer, file e3ad8926-cc42-da0e-e053-3705fe0a2b96
|
98
|
|
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study, file e3ad8923-e0e0-da0e-e053-3705fe0a2b96
|
89
|
|
Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial, file e3ad8926-ce56-da0e-e053-3705fe0a2b96
|
85
|
|
Metronomic oral vinorelbine in patients with advanced non-small cell lung cancer progressing after nivolumab immunotherapy: a retrospective analysis, file e3ad8922-fef7-da0e-e053-3705fe0a2b96
|
80
|
|
Effects of the number of removed lymph nodes on survival outcome in patients with sentinel node-negative breast cancer, file e3ad8927-53d8-da0e-e053-3705fe0a2b96
|
70
|
|
A Case of Follicular Tumor of Uncertain Malignant Potential (FT-UMP) with Glomeruloid Features Showing Capsular Mucinous Degeneration, file e3ad8926-7142-da0e-e053-3705fe0a2b96
|
60
|
|
Harmful Interference of Detoxifying Diets and Nutraceuticals with Adherence to Abemaciclib in Advanced Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Breast Cancer: A Case Report, file e3ad8927-1ec6-da0e-e053-3705fe0a2b96
|
53
|
|
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial, file e3ad8927-0395-da0e-e053-3705fe0a2b96
|
52
|
|
Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers, file e3ad891a-4e07-da0e-e053-3705fe0a2b96
|
46
|
|
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers, file e3ad8917-1414-da0e-e053-3705fe0a2b96
|
38
|
|
Safety and activity of trastuzumab-containing therapies for the treatment of metastatic breast cancer: our long-term clinical experience (GOIM study)., file e3ad8915-d154-da0e-e053-3705fe0a2b96
|
34
|
|
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study., file e3ad8915-dc78-da0e-e053-3705fe0a2b96
|
34
|
|
Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study., file e3ad8915-f197-da0e-e053-3705fe0a2b96
|
30
|
|
TP53 in gastric cancer: mutations in the l3 loop and LSH motif DNA-binding domains of TP53 predict poor outcome, file e3ad891a-56a7-da0e-e053-3705fe0a2b96
|
27
|
|
DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: Results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study, file e3ad8923-45d8-da0e-e053-3705fe0a2b96
|
23
|
|
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting, file e3ad8928-d531-da0e-e053-3705fe0a2b96
|
19
|
|
p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: A prospective study with a five-year follow-up, file e3ad8916-75e3-da0e-e053-3705fe0a2b96
|
15
|
|
Oral vinorelbine and capecitabine as first-line therapy in metastatic breast cancer: a retrospective analysis, file e3ad8927-4550-da0e-e053-3705fe0a2b96
|
13
|
|
WhatsApp Messenger use in oncology: a narrative review on pros and contras of a flexible and practical, non-specific communication tool, file e3ad8927-da46-da0e-e053-3705fe0a2b96
|
13
|
|
Current Role of Intraoperative Frozen Section Examination of Sentinel Lymph Node in Early Breast Cancer, file e3ad8921-8261-da0e-e053-3705fe0a2b96
|
11
|
|
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study, file 36c237c8-f900-4618-ab2b-d401e61711c2
|
8
|
|
Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated?, file e3ad8920-aeb8-da0e-e053-3705fe0a2b96
|
8
|
|
Patients With Cancer and COVID-19: A WhatsApp Messenger-Based Survey of Patients' Queries, Needs, Fears, and Actions Taken, file e3ad8922-4e8b-da0e-e053-3705fe0a2b96
|
8
|
|
High-dose Radiotherapy for Oligo-progressive NSCLC Receiving EGFR Tyrosine Kinase Inhibitors: Real World Data, file e3ad8922-a180-da0e-e053-3705fe0a2b96
|
8
|
|
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study, file e3ad8921-a028-da0e-e053-3705fe0a2b96
|
7
|
|
Letter to the Editor: statistics and clinical perception of patients' reported outcomes for palbociclib and abemaciclib: a sliding doors story, file 2afda8a9-5b1a-487e-a592-0229820e76a2
|
5
|
|
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2â) advanced breast cancer patients: New insights beyond clinical trials. The EVA study, file e3ad891d-35f9-da0e-e053-3705fe0a2b96
|
5
|
|
Stereotactic Radiotherapy for the Treatment of Patients With Oligo-progressive Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor: Data From the Real World, file e3ad8923-e0df-da0e-e053-3705fe0a2b96
|
5
|
|
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study, file e3ad8927-72ec-da0e-e053-3705fe0a2b96
|
5
|
|
Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer, file e3ad891f-60ce-da0e-e053-3705fe0a2b96
|
4
|
|
NEPA as antiemetic prophylaxis after failure of 5HT3-RA plus dexamethasone in patients receiving carboplatin and gemcitabine chemotherapy: A monocentric real-life experience, file e3ad8922-5398-da0e-e053-3705fe0a2b96
|
4
|
|
A Prospective Observational Study on the Structuring Process and Implementation of a Large Regional, Inter-hospital, Virtual Multidisciplinary Tumor Board on Prostate Cancer, file 1a4df79f-ce3f-44b8-85b6-f9a9be57db5c
|
3
|
|
Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer, file a80bc726-ac56-4fae-88c5-0fc307c8f37d
|
3
|
|
Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: The G-Step trial, file e3ad8920-16b8-da0e-e053-3705fe0a2b96
|
3
|
|
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence, file e3ad8921-b368-da0e-e053-3705fe0a2b96
|
3
|
|
Does Smoking Cessation at Primary Diagnosis Reduce the Recurrence Risk of Nonmuscle-Invasive Bladder Cancer? Results of a Prospective Study, file e3ad8922-0628-da0e-e053-3705fe0a2b96
|
3
|
|
Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer: A Multi-institutional Real-world Report on Efficacy and Safety, file e3ad8926-0bf8-da0e-e053-3705fe0a2b96
|
3
|
|
Stereotactic Radiotherapy in Early-Stage Breast Cancer in Neoadjuvant and Exclusive Settings: A Systematic Review, file bdaf7548-a275-45ec-8387-74727fc7da38
|
2
|
|
Alexithymia and coping style in women going to visit in a breast cancer center., file e3ad891d-5706-da0e-e053-3705fe0a2b96
|
2
|
|
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies, file e3ad891f-1d1e-da0e-e053-3705fe0a2b96
|
2
|
|
Is G8 geriatric assessment tool useful in managing elderly patients with metastatic pancreatic carcinoma?, file e3ad8922-e776-da0e-e053-3705fe0a2b96
|
2
|
|
DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study, file e3ad8922-f240-da0e-e053-3705fe0a2b96
|
2
|
|
Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients, file 17f2cf93-0852-4615-8f89-39d69f10e83d
|
1
|
|
Correction to: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer (npj Breast Cancer, file 45a0dc00-2f71-4e23-96a4-ef497be01e80
|
1
|
|
Outcomes of Sentinel Lymph Node Biopsy for Patients With Node-positive Breast Cancer Treated With Neoadjuvant Chemotherapy, file 795caaeb-3bdc-47d2-af4b-90ac26ea1b02
|
1
|
|
Abemaciclib-associated Diarrhea: An Exploratory Analysis of Real-life Data, file 931f7650-d7b9-4a01-a79f-651bf212670e
|
1
|
|
Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer (npj Breast Cancer, file a03840e8-4516-4cdd-9093-50a0daf27245
|
1
|
|
Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study., file e3ad8915-9585-da0e-e053-3705fe0a2b96
|
1
|
|
Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced
non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E and
CALC1-PS2) randomized phase II trials., file e3ad8915-9762-da0e-e053-3705fe0a2b96
|
1
|
|
Liposomal-encapsulated doxorubicin plus cyclophosphamide as first-line therapy in metastatic breast cancer: a phase II multicentric study, file e3ad8915-fc86-da0e-e053-3705fe0a2b96
|
1
|
|
Salvage Therapy With Oral Metronomic Cyclophosphamide and Methotrexate for Castration refractory Metastatic Adenocarcinoma
of the Prostate Resistant to Docetaxel, file e3ad8915-fdd4-da0e-e053-3705fe0a2b96
|
1
|
|
Effects of hypolipidemic and hypoglycemic
agents on atherogenic small, dense LDL in
Type 2 diabetes, file e3ad8916-6534-da0e-e053-3705fe0a2b96
|
1
|
|
Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancer, file e3ad8917-6756-da0e-e053-3705fe0a2b96
|
1
|
|
Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma, file e3ad8917-6b42-da0e-e053-3705fe0a2b96
|
1
|
|
Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA), file e3ad891f-c7d8-da0e-e053-3705fe0a2b96
|
1
|
|
The HERBA trial: a retrospective study on patients (pts) with HER2-positive (HER2+ve) breast cancer (BC) and brain metastases (BMs), file e3ad8921-f4cd-da0e-e053-3705fe0a2b96
|
1
|
|
Impressive objective response to nab-paclitaxel plus trastuzumab as fifth line therapy in aelderly her2-positive breast cancer patient, file e3ad8922-f1a4-da0e-e053-3705fe0a2b96
|
1
|
|
Gastric metastasis from breast cancer, file e3ad8923-0655-da0e-e053-3705fe0a2b96
|
1
|
|
Lapatinib activity in a patient with encephalic metastases from trastuzumab-resistant her-2 positive breast cancer, file e3ad8923-3364-da0e-e053-3705fe0a2b96
|
1
|
| Totale |
3.803 |